Stockholm - Delayed Quote SEK
Karolinska Development AB (publ) (KDEV.ST)
At close: October 18 at 5:22 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
1,903.0000
2,014.0000
2,300.0000
2,170.0000
2,651.0000
--
Operating Expense
30,582.0000
29,595.0000
34,073.0000
30,782.0000
32,776.0000
--
Operating Income
-28,679.0000
-27,581.0000
-31,773.0000
-28,612.0000
-30,125.0000
--
Net Non Operating Interest Income Expense
6,689.0000
7,297.0000
572.0000
10,122.0000
-4,780.0000
--
Pretax Income
-5,649.0000
5,386.0000
-88,122.0000
170,819.0000
-207,487.0000
--
Net Income Common Stockholders
-5,649.0000
5,386.0000
-88,122.0000
170,819.0000
-207,487.0000
--
Diluted NI Available to Com Stockholders
-5,649.0000
5,386.0000
-88,122.0000
170,819.0000
-207,487.0000
--
Basic EPS
-0.02
0.02
-0.34
0.97
-1.04
--
Diluted EPS
-0.02
0.02
-0.34
0.97
-1.04
--
Basic Average Shares
269,833.3090
269,833.3090
257,417.4600
175,421.1240
198,095.5320
--
Diluted Average Shares
269,833.3090
269,833.3090
257,417.4600
175,421.1240
198,095.5320
--
Total Operating Income as Reported
-13,932.0000
-3,505.0000
-87,421.0000
160,700.0000
-202,426.0000
--
Total Expenses
30,582.0000
29,595.0000
34,073.0000
30,782.0000
32,776.0000
--
Net Income from Continuing & Discontinued Operation
-5,649.0000
5,386.0000
-88,122.0000
170,819.0000
-207,487.0000
--
Normalized Income
-21,990.0000
-20,284.0000
-31,206.0000
-18,493.0000
-35,186.0000
--
Interest Income
--
7,297.0000
1,416.0000
6,406.0000
908.0000
--
Interest Expense
--
--
844.0000
6,284.0000
5,688.0000
--
Net Interest Income
6,689.0000
7,297.0000
572.0000
10,122.0000
-4,780.0000
--
EBIT
4,288.0000
5,386.0000
-87,278.0000
177,103.0000
-201,799.0000
--
EBITDA
5,228.0000
6,184.0000
-86,588.0000
177,793.0000
-201,109.0000
--
Reconciled Depreciation
940.0000
798.0000
690.0000
690.0000
690.0000
--
Net Income from Continuing Operation Net Minority Interest
-5,649.0000
5,386.0000
-88,122.0000
170,819.0000
-207,487.0000
--
Total Unusual Items Excluding Goodwill
16,341.0000
25,670.0000
-56,916.0000
189,312.0000
-172,301.0000
--
Total Unusual Items
16,341.0000
25,670.0000
-56,916.0000
189,312.0000
-172,301.0000
--
Normalized EBITDA
-11,113.0000
-19,486.0000
-29,672.0000
-11,519.0000
-28,808.0000
--
12/31/2019 - 4/15/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALTE.ST Alteco Medical AB
0.3200
+41.59%
GNRO.PA GeNeuro SA
0.0828
+7.25%
AELIS.PA Aelis Farma SA
3.6000
-8.63%
QUIA.ST Quia Pharma AB (publ)
0.0200
-6.10%
2CUREX.ST 2cureX AB (publ)
0.5800
-13.43%
ELIC.ST Elicera Therapeutics AB (publ)
1.5300
-6.71%
CMOTEC-B.ST Scandinavian ChemoTech AB (publ)
1.9200
+1.59%
IMMU.ST Mendus AB (publ)
8.19
+1.10%
CYXO.ST Cyxone AB (publ)
0.0400
-2.44%
ABLI.ST Abliva AB (publ)
0.1550
+1.04%